Long-Term Effects on QT Prolongation of Pretomanid Alone and in Combinations in Patients with Tuberculosis

Concentration-QTc modeling was applied to pretomanid, a new nitroimidazooxazine antituberculosis drug. Data came from eight phase 2 and phase 3 studies. Besides pretomanid alone, various combinations with bedaquiline, linezolid, moxifloxacin, and pyrazinamide were considered; special attention was g...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hanbin, Salinger, David H., Everitt, Daniel, Li, Mengchun, Del Parigi, Angelo, Mendel, Carl, Nedelman, Jerry R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2019
Materias:
Clinical Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761551/
https://www.ncbi.nlm.nih.gov/pubmed/31358590
http://dx.doi.org/10.1128/AAC.00445-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761551/
https://www.ncbi.nlm.nih.gov/pubmed/31358590
http://dx.doi.org/10.1128/AAC.00445-19

Ejemplares similares